Genmab — Februar 2016
-
Hvad sker der lige
-
GSK benyttede magien omkring RRMM data i februar sidste år til at sælge deres 7,9% og de ejer således ikke en eneste aktie i GEN længere
-
med den her transaktion er den eneste betydende aktionær i GEN sålede amerikanske Fidelity med 10%
-
Novod fra Nordea "Major buying opportunity i Genmab"
-
Jeg har fisket. Desværre over 750.

-
det er JJ, der sælger hele balladen. De 1,1m er en "afdækningstransaktion"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind